Kazia Therapeutics (KZIA) Notes Payables (2022 - 2025)

Kazia Therapeutics' Notes Payables history spans 4 years, with the latest figure at $253611.5 for Q2 2025.

  • For Q2 2025, Notes Payables fell 39.3% year-over-year to $253611.5; the TTM value through Jun 2025 reached $253611.5, down 39.3%, while the annual FY2025 figure was $253611.5, 39.3% down from the prior year.
  • Notes Payables reached $253611.5 in Q2 2025 per KZIA's latest filing, down from $417821.5 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $1.2 million in Q2 2023 to a low of -$1.3 million in Q2 2022.
  • Average Notes Payables over 4 years is $138289.6, with a median of $335716.5 recorded in 2024.
  • Peak YoY movement for Notes Payables: surged 191.03% in 2023, then plummeted 65.19% in 2024.
  • A 4-year view of Notes Payables shows it stood at -$1.3 million in 2022, then soared by 191.03% to $1.2 million in 2023, then tumbled by 65.19% to $417821.5 in 2024, then crashed by 39.3% to $253611.5 in 2025.
  • Per Business Quant, the three most recent readings for KZIA's Notes Payables are $253611.5 (Q2 2025), $417821.5 (Q2 2024), and $1.2 million (Q2 2023).